Saturday, Apr 10, 2021
Focus on the big picture

AstraZeneca U.S. trial data gives vaccine a boost

Reuters, 22 Mar 2021
AstraZeneca’s COVID-19 vaccine performed better than expected in a major late-stage trial potentially paving the way for its emergency authorization in the United States and bolstering confidence in the shot after numerous setbacks in Europe.

#News #Reuters #coronavirus #COVID19 #vaccine #AstraZeneca


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram:
Related Articles